These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26021499)

  • 21. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.
    Chung MK; Martin DO; Sprecher D; Wazni O; Kanderian A; Carnes CA; Bauer JA; Tchou PJ; Niebauer MJ; Natale A; Van Wagoner DR
    Circulation; 2001 Dec; 104(24):2886-91. PubMed ID: 11739301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Atorvastatin on Serum High-Sensitive C-Reactive Protein and Total Cholesterol Levels in Asian Patients With Atrial Fibrillation.
    Wang J; Wang AR; Zhang MJ; Li Y
    Am J Ther; 2017; 24(1):e20-e29. PubMed ID: 26566148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of interleukin-1 gene cluster polymorphisms in lone atrial fibrillation: new insight into the role of inflammation in atrial fibrillation.
    Gungor B; Ekmekci A; Arman A; Ozcan KS; Ucer E; Alper AT; Calik N; Yilmaz H; Tezel T; Coker A; Bolca O
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1220-7. PubMed ID: 23713812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.
    Hu B; Sun Y; Li S; Sun J; Liu T; Wu Z; Feng LI
    Pacing Clin Electrophysiol; 2016 Dec; 39(12):1379-1387. PubMed ID: 27862036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation.
    Han W; Fu S; Wei N; Xie B; Li W; Yang S; Li Y; Liang Z; Huo H
    Int J Cardiol; 2008 Nov; 130(2):165-73. PubMed ID: 18585800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome, high-sensitivity C-reactive protein levels and the risk of new-onset atrial fibrillation: Results from the Kailuan Study.
    Wang Z; Wang B; Li X; Zhang S; Wu S; Xia Y
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):102-109. PubMed ID: 33500102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation.
    Henningsen KM; Nilsson B; Bruunsgaard H; Chen X; Pedersen BK; Svendsen JH
    Scand Cardiovasc J; 2009; 43(5):285-91. PubMed ID: 19117239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P Wave Dispersion and Silent Atrial Fibrillation in Cryptogenic Stroke: The Pathogenic Role of Inflammation.
    Acampa M; Lazzerini PE; Guideri F; Tassi R; Cartocci A; Martini G
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(3):249-252. PubMed ID: 30968778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Dawood FZ; Judd S; Howard VJ; Limdi NA; Meschia JF; Cushman M; Howard G; Herrington DM; Soliman EZ
    Am J Cardiol; 2016 Dec; 118(12):1826-1830. PubMed ID: 27712649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation.
    Lim HS; Schultz C; Dang J; Alasady M; Lau DH; Brooks AG; Wong CX; Roberts-Thomson KC; Young GD; Worthley MI; Sanders P; Willoughby SR
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):83-9. PubMed ID: 24446024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can neutrophil/lymphocyte ratio predict recurrence of non-valvular atrial fibrillation after cardioversion?
    Arıbaş A; Akıllı H; Gül EE; Kayrak M; Demir K; Duman C; Alibasiç H; Yazıcı M; Ozdemir K; Gök H
    Anadolu Kardiyol Derg; 2013 Mar; 13(2):123-30. PubMed ID: 23228974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of elevation of C-reactive protein in atrial fibrillation.
    Anderson JL; Allen Maycock CA; Lappé DL; Crandall BG; Horne BD; Bair TL; Morris SR; Li Q; Muhlestein JB;
    Am J Cardiol; 2004 Nov; 94(10):1255-9. PubMed ID: 15541240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation - preliminary report.
    Sokal A; Wójcik S; Pruszkowska P; Kowalski O; Lenarczyk R; Liberska A; Mazurek M; Pluta S; Kalarus Z
    Postepy Hig Med Dosw (Online); 2017 Oct; 71(0):876-880. PubMed ID: 29039347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma oxidative stress and inflammatory biomarkers are associated with the sizes of the left atrium and pulmonary vein in atrial fibrillation patients.
    Li JY; He Y; Ke HH; Jin Y; Jiang ZY; Zhong GQ
    Clin Cardiol; 2017 Feb; 40(2):89-94. PubMed ID: 28207162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.